High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group
- PMID: 26148192
- PMCID: PMC4492974
- DOI: 10.1371/journal.pone.0131001
High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group
Abstract
Objective: Many studies include oral HIV-related endpoints that may be diagnosed by non-oral-health specialists (non-OHS) like nurses or physicians. Our objective was to assess the accuracy of clinical diagnoses of HIV-related oral lesions made by non-OHS compared to diagnoses made by OHS.
Methods: A5254, a cross-sectional study conducted by the Oral HIV/AIDS Research Alliance within the AIDS Clinical Trial Group, enrolled HIV-1-infected adults participants from six clinical trial units (CTU) in the US (San Francisco, New York, Chapel Hill, Cleveland, Atlanta) and Haiti. CTU examiners (non-OHS) received standardized training on how to perform an oral examination and make clinical diagnoses of specific oral disease endpoints. Diagnoses by calibrated non-OHS were compared to those made by calibrated OHS, and sensitivity and specificity computed.
Results: Among 324 participants, the majority were black (73%), men (66%), and the median CD4+ cell count 138 cells/mm(3). The overall frequency of oral mucosal disease diagnosed by OHS was 43% in US sites, and 90% in Haiti. Oral candidiasis (OC) was detected in 153 (47%) by OHS, with erythematous candidiasis (EC) the most common type (39%) followed by pseudomembranous candidiasis (PC; 26%). The highest prevalence of OC (79%) was among participants in Haiti, and among those with CD4+ cell count ≤ 200 cells/mm(3) and HIV-1 RNA > 1000 copies/mL (71%). The sensitivity and specificity of OC diagnoses by non-OHS were 90% and 92% (for EC: 81% and 94%; PC: 82% and 95%). Sensitivity and specificity were also high for KS (87% and 94%, respectively), but sensitivity was < 60% for HL and oral warts in all sites combined. The Candida culture confirmation of OC clinical diagnoses (as defined by ≥ 1 colony forming unit per mL of oral/throat rinse) was ≥ 93% for both PC and EC.
Conclusion: Trained non-OHS showed high accuracy of clinical diagnoses of OC in comparison with OHS, suggesting their usefulness in studies in resource-poor settings, but detection of less common lesions may require OHS.
Conflict of interest statement
References
-
- Feigal DW, Katz MH, Greenspan D, Westenhouse J, Winkelstein W Jr, Lang W, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991;5: 519–525. - PubMed
-
- Katz MH, Greenspan D, Westenhouse J, Hessol NA, Buchbinder SP, Lifson AR, et al. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 1992;6: 95–100. - PubMed
-
- Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994;77: 344–349. - PubMed
-
- Shiboski CH, Hilton JF, Greenspan D, Westenhouse JL, Derish P, Vranizan K, et al. HIV-related oral manifestations in two cohorts of women in San Francisco. J Acquir Immune Defic Syndr 1994;7: 964–971. - PubMed
-
- Shiboski CH, Hilton JF, Neuhaus JM, Canchola A, Greenspan D. Human immunodeficiency virus-related oral manifestations and gender. A longitudinal analysis. Arch Intern Med 1996;156: 2249–2254. - PubMed
Publication types
MeSH terms
Grants and funding
- UM1 AI069423/AI/NIAID NIH HHS/United States
- UM1 AI069501/AI/NIAID NIH HHS/United States
- P30 AI050409/AI/NIAID NIH HHS/United States
- UL1 TR001111/TR/NCATS NIH HHS/United States
- U01 AI069418/AI/NIAID NIH HHS/United States
- R01 DE018304/DE/NIDCR NIH HHS/United States
- UM1 AI069470/AI/NIAID NIH HHS/United States
- UM1 AI068634/AI/NIAID NIH HHS/United States
- U01 AI069501/AI/NIAID NIH HHS/United States
- U01AI068634/AI/NIAID NIH HHS/United States
- U01 AI069421/AI/NIAID NIH HHS/United States
- U01 AI068636/AI/NIAID NIH HHS/United States
- UM1 AI069496/AI/NIAID NIH HHS/United States
- UM1 AI069532/AI/NIAID NIH HHS/United States
- UL1 RR025008/RR/NCRR NIH HHS/United States
- U01AI068636/AI/NIAID NIH HHS/United States
- U01 AI068634/AI/NIAID NIH HHS/United States
- UM1 AI068636/AI/NIAID NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials